TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Tuesday reported a loss of $22.2 million in its fourth quarter.
On a per-share basis, the Tucson, Arizona-based company said it had a loss of 41 cents.
The results matched Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 41 cents per share.
The maker of systems that diagnose drug-resistant infections posted revenue of $1.8 million in the period.
For the year, the company reported that its loss widened to $88.3 million, or $1.62 per share. Revenue was reported as $5.7 million.
Accelerate Diagnostics shares have climbed 69 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $19.47, a decline of 23 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXDX at https://www.zacks.com/ap/AXDX